Á lódáil...
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Schizophrenia affects approximately 1% of the population and continues to be associated with poor outcome because of the limited efficacy of and noncompliance with existing antipsychotic medications. An alternative hypothesis invoking the excitatory neurotransmitter, glutamate, arose out of clinical...
Na minha lista:
| Foilsithe in: | Handb Exp Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2012
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817347/ https://ncbi.nlm.nih.gov/pubmed/23027419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-642-25758-2_10 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|